Enhancer-Addicted Prostate Cancer Is Sensitive to SWI/SNF Degradation

Area of Science:

• Oncology
• Molecular Biology
• Cancer Genetics

Background:

• Prostate cancer often depends on specific genetic alterations for growth.
• The SWI/SNF chromatin remodeling complex plays a critical role in cancer development.
• Enhancer elements are crucial regulatory regions driving gene expression in cancer.

Purpose of the Study:

• To investigate the impact of SWI/SNF ATPase protein degradation on prostate cancer cells.
• To determine if targeting SWI/SNF ATPase leads to cytotoxicity in enhancer-addicted prostate cancer.
• To explore potential therapeutic vulnerabilities in prostate cancer.

Main Methods:

• Utilized genetic manipulation to induce SWI/SNF ATPase protein degradation in prostate cancer cell lines.
• Assessed cell viability and cytotoxicity following protein degradation.
• Analyzed the role of enhancer activity in mediating sensitivity to SWI/SNF ATPase loss.

Main Results:

• Degradation of SWI/SNF ATPase proteins resulted in significant cytotoxicity in prostate cancer cells.
• Cells with high dependence on enhancers (enhancer-addicted) were particularly sensitive to SWI/SNF ATPase loss.
• This suggests a specific vulnerability in a subset of prostate cancers.

Conclusions:

• Targeting SWI/SNF ATPase protein degradation is a viable strategy to induce cell death in enhancer-addicted prostate cancer.
• This approach offers a novel therapeutic avenue for a specific molecular subtype of prostate cancer.
• Further research into SWI/SNF pathways could reveal new treatments for advanced prostate cancer.